» Articles » PMID: 11463365

Inositol Lipids Are Regulated During Cell Cycle Progression in the Nuclei of Murine Erythroleukaemia Cells

Overview
Journal Biochem J
Specialty Biochemistry
Date 2001 Jul 21
PMID 11463365
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Previous data suggest the existence of discrete pools of inositol lipids, which are components of a nuclear phosphoinositide (PI) cycle. However, it is not known whether the contents of these pools are regulated during cell proliferation. In the present study we demonstrate that the mass levels of three important constituents of the nuclear PI cycle are regulated during the cell cycle. Radioactive label incorporation into PtdIns(4,5)P(2) was seen to increase dramatically as synchronized cells entered S-phase. This did not coincide with any significant changes in the nuclear mass levels of this lipid, suggesting that the rate of turnover of this molecule was increased. Levels of PtdIns4P, the major substrate for PtdIns(4,5)P(2) production by Type I PtdInsP kinases (PIPkins), were regulated during the cell cycle and indicated a complex relationship between these two lipids. An alternative substrate for PtdIns(4,5)P(2), PtdIns5P, phosphorylated by Type II PIPkins, was present in nuclei at much smaller amounts than the PtdIns4P, and thus is unlikely to contribute significantly to PtdIns(4,5)P(2) turnover. However, a large increase in nuclear PtdIns5P mass was observed when murine erythroleukaemia cells are in G(1), and this could represent a potential pool of nuclear inositol lipid that has a specific signalling role. Analysis of extracted lipid fractions indicated the absence of any PtdIns3P in these nuclei.

Citing Articles

Nuclear Phosphoinositides as Key Determinants of Nuclear Functions.

Vidalle M, Sheth B, Fazio A, Marvi M, Leto S, Koufi F Biomolecules. 2023; 13(7).

PMID: 37509085 PMC: 10377365. DOI: 10.3390/biom13071049.


When PIP Meets p53: Nuclear Phosphoinositide Signaling in the DNA Damage Response.

Wang Y, Sheetz M Front Cell Dev Biol. 2022; 10:903994.

PMID: 35646908 PMC: 9136457. DOI: 10.3389/fcell.2022.903994.


The basis of nuclear phospholipase C in cell proliferation.

Gomes D, de Miranda M, Faria J, Rodrigues M Adv Biol Regul. 2021; 82:100834.

PMID: 34710785 PMC: 8671340. DOI: 10.1016/j.jbior.2021.100834.


Mapping metabolic oscillations during cell cycle progression.

Roci I, Watrous J, Lagerborg K, Jain M, Nilsson R Cell Cycle. 2020; 19(20):2676-2684.

PMID: 33016215 PMC: 7644150. DOI: 10.1080/15384101.2020.1825203.


The nuclear phosphoinositide response to stress.

Chen M, Wen T, Horn H, Chandrahas V, Thapa N, Choi S Cell Cycle. 2020; 19(3):268-289.

PMID: 31902273 PMC: 7028212. DOI: 10.1080/15384101.2019.1711316.


References
1.
Boronenkov I, Loijens J, Umeda M, Anderson R . Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell. 1998; 9(12):3547-60. PMC: 25675. DOI: 10.1091/mbc.9.12.3547. View

2.
Dsantos C, Clarke J, Divecha N . Phospholipid signalling in the nucleus. Een DAG uit het leven van de inositide signalering in de nucleus. Biochim Biophys Acta. 1998; 1436(1-2):201-32. DOI: 10.1016/s0005-2760(98)00146-5. View

3.
BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

4.
Ciruela A, Hinchliffe K, Divecha N, Irvine R . Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7. Biochem J. 2000; 346 Pt 3:587-91. PMC: 1220889. View

5.
Morris J, Hinchliffe K, Ciruela A, Letcher A, Irvine R . Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay. FEBS Lett. 2000; 475(1):57-60. DOI: 10.1016/s0014-5793(00)01625-2. View